Business & Finance News, In Brief
Executive Summary
Generic Lovenox, Alcon Acquisition Driving Novartis Growth
You may also be interested in...
Amphastar Lawsuit Over Heparin Shipments Suggests Lovenox ANDA Approval May Be Far Off
Allegations in Amphastar Pharmaceuticals’ lawsuit over FDA detention of heparin raw ingredient shipments suggest approval of its enoxaparin ANDA, the generic of Sanofi-Aventis’ low-molecular weight heparin Lovenox, is far from imminent.
Amphastar Lawsuit Over Heparin Shipments Suggests Lovenox ANDA Approval May Be Far Off
Allegations in Amphastar Pharmaceuticals’ lawsuit over FDA detention of heparin raw ingredient shipments suggest approval of its enoxaparin ANDA, the generic of Sanofi-Aventis’ low-molecular weight heparin Lovenox, is far from imminent.
Roche Gets Reprieve On Avastin For Breast Cancer With Delay At FDA
FDA extends user fee date in lieu of reaching decision on whether or not to pull the breast cancer approval for bevacizumab.